Mats Wahlstrom - Nov 22, 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director, 10%+ Owner
Signature
/s/ Sean Murphy, Attorney-in-Fact
Stock symbol
TLSI
Transactions as of
Nov 22, 2024
Transactions value $
$22,750
Form type
4
Date filed
11/25/2024, 05:53 PM
Previous filing
Nov 22, 2024
Next filing
Dec 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Purchase $22.8K +5K +46.61% $4.55 15.7K Nov 22, 2024 Direct F1
holding TLSI Common Stock 1.25M Nov 22, 2024 By Leonard Capital LLC F2
holding TLSI Common Stock 1.37M Nov 22, 2024 By HW Investment Partners, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
F3 The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.